GNH USA

Europe — EMA

Levodopa/Carbidopa Monohydrate Axcount

GNH USA supplies Levodopa/Carbidopa Axcount (Levodopa/Carbidopa), a dopaminergic therapy for Parkinson's disease and related syndromes. Request a quote.

Levodopa, Carbidopa Monohydrate

Request sourcing

1
Pack/s

What is Levodopa, Carbidopa Monohydrate?

Levodopa/Carbidopa, the active ingredient in Levodopa/Carbidopa Monohydrate Axcount, is an antiparkinson agent presented as an oral tablet for oral use. It treats Parkinson's disease and related parkinsonian syndromes in adult patients.

GNH USA supplies Levodopa/Carbidopa Monohydrate Axcount as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. All batches are manufactured under EU GMP standards and undergo rigorous quality testing before release. The company provides regulatory support and reliable logistics to ensure timely delivery across multiple continents.

What is Levodopa, Carbidopa Monohydrate used for?

Levodopa/Carbidopa is used in the management of Parkinsonian disorders, improving motor function by replenishing central dopamine.

- Parkinson's disease: reduces bradykinesia, rigidity, and tremor, improving overall motor performance. - Parkinsonian syndrome: alleviates symptoms in secondary parkinsonism conditions, enhancing daily activities. - Levodopa‑responsive motor fluctuations: smooths off periods and extends on‑time when combined with carbidopa.

What are the side effects of Levodopa, Carbidopa Monohydrate?

Levodopa/Carbidopa may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea or vomiting. - Dizziness or light‑headedness, especially on standing. - Headache. - Orthostatic hypotension.

Serious or Rare Side Effects: - Dyskinesia (involuntary movements). - Neuroleptic malignant syndrome or severe psychiatric disturbances. - Cardiac arrhythmias. - Severe skin reactions such as Stevens‑Johnson syndrome.

What precautions apply to Levodopa, Carbidopa Monohydrate?

Levodopa/Carbidopa requires careful monitoring and individualized dosing.

- Dose titration: start low and increase gradually under medical supervision. - Monitor for dyskinesia: adjust therapy if involuntary movements develop. - Assess renal/hepatic function: consider dose adjustment in impairment. - Avoid abrupt discontinuation: taper to prevent withdrawal symptoms. - Store at ambient temperature: keep in original container, protect from moisture and light.

What does Levodopa, Carbidopa Monohydrate interact with?

Levodopa/Carbidopa interacts with several drug classes that can alter its efficacy or safety.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Anticholinergic agents: may mask motor symptom changes. - High‑protein meals: reduce levodopa absorption.

Moderate Interactions (Monitor Closely): - Selective MAO‑B inhibitors: may enhance dopaminergic effects. - Iron or calcium supplements: decrease levodopa bioavailability; separate dosing by at least 2 hours. - Antidepressants (SSRIs, SNRIs): monitor for serotonin syndrome.

Frequently asked questions

What is Levodopa/Carbidopa Monohydrate Axcount used for?+
Levodopa/Carbidopa Monohydrate Axcount is prescribed to manage the motor symptoms of Parkinson's disease and other Parkinsonian syndromes. By increasing dopamine levels in the brain, it helps reduce tremor, rigidity, and slowness of movement, improving patients' daily functioning.
How does Levodopa work in the body?+
Levodopa is a precursor of dopamine that crosses the blood‑brain barrier. Once inside the central nervous system, it is converted to dopamine, replenishing the depleted neurotransmitter that is characteristic of Parkinson's disease. Carbidopa prevents this conversion in the periphery, allowing more levodopa to reach the brain.
What determines the usual dose of Levodopa/Carbidopa?+
The exact dose is individualized and set by the prescribing clinician based on the patient’s disease severity, response to therapy, age, and co‑existing medical conditions. Physicians typically start with a low dose and adjust gradually to achieve optimal symptom control while minimizing side effects.
Is Levodopa/Carbidopa safe during pregnancy or breastfeeding?+
Safety data in pregnancy and lactation are limited. The medication should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.
How do I order Levodopa/Carbidopa Monohydrate Axcount from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, indicating the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Levodopa/Carbidopa compare with other Parkinson’s treatments?+
Levodopa/Carbidopa is considered the most effective dopaminergic therapy for motor symptom control, whereas dopamine agonists or MAO‑B inhibitors are often used as adjuncts or early‑stage options. Levodopa provides stronger symptomatic relief but may be associated with motor complications such as dyskinesia over long‑term use.
What are the storage and handling requirements for this product?+
Store the tablets at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children. Do not store in humid or excessively hot environments.
How is Levodopa/Carbidopa administered?+
Levodopa/Carbidopa is taken orally, usually with a glass of water. It can be taken with or without food, although high‑protein meals may interfere with absorption. Patients should follow the dosing schedule prescribed by their clinician and avoid crushing or chewing the tablets unless directed otherwise.
What are the most serious risks associated with Levodopa/Carbidopa?+
Serious risks include the development of dyskinesia (involuntary movements), neuroleptic malignant syndrome, severe psychiatric disturbances such as hallucinations or depression, and rare cardiac arrhythmias. Prompt medical attention is required if any of these symptoms emerge.
Who should not use Levodopa/Carbidopa?+
Patients with known hypersensitivity to levodopa, carbidopa, or any excipients should avoid the product. It is also contraindicated in individuals taking non‑selective MAO inhibitors, those with narrow‑angle glaucoma, or patients with severe cardiovascular disease unless specifically advised by a physician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Levodopa, Carbidopa Monohydrate
Route
Oral Use
Manufacturer
Axcount Generika Gmbh
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU